2-[3-(2-methyl-1,3-benzoxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]-7-[2-[4-[5-(1-methyl-1,2,4-triazol-3-yl)-1,3-thiazol-2-yl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one
C34H33N11O3S — CID 154961241
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3-(2-methyl-1,3-benzoxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]-7-[2-[4-[5-(1-methyl-1,2,4-triazol-3-yl)-1,3-thiazol-2-yl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one
2-[3-(2-methyl-1,3-benzoxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]-7-[2-[4-[5-(1-methyl-1,2,4-triazol-3-yl)-1,3-thiazol-2-yl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one (PubChem CID 154961241) has the molecular formula C34H33N11O3S and a molecular weight of 675.78 g/mol. Its IUPAC name is 2-[3-(2-methyl-1,3-benzoxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]-7-[2-[4-[5-(1-methyl-1,2,4-triazol-3-yl)-1,3-thiazol-2-yl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one.
Molecular Properties
| Compound Name | 2-[3-(2-methyl-1,3-benzoxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]-7-[2-[4-[5-(1-methyl-1,2,4-triazol-3-yl)-1,3-thiazol-2-yl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one |
|---|---|
| PubChem CID | 154961241 |
| Molecular Formula | C34H33N11O3S |
| Molecular Weight | 675.78 g/mol |
| Exact Mass | 675.25 |
| IUPAC Name | 2-[3-(2-methyl-1,3-benzoxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]-7-[2-[4-[5-(1-methyl-1,2,4-triazol-3-yl)-1,3-thiazol-2-yl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-2,7-diazaspiro[4.4]nonan-1-one |
| SMILES | Cc1nc2cc(-c3n[nH]c4ccc(N5CCC6(CCN(CC(=O)N7CC=C(c8ncc(-c9ncn(C)n9)s8)CC7)C6)C5=O)nc34)ccc2o1 |
| InChI | InChI=1S/C34H33N11O3S/c1-20-37-24-15-22(3-5-25(24)48-20)29-30-23(39-40-29)4-6-27(38-30)45-14-10-34(33(45)47)9-13-43(18-34)17-28(46)44-11-7-21(8-12-44)32-35-16-26(49-32)31-36-19-42(2)41-31/h3-7,15-16,19H,8-14,17-18H2,1-2H3,(H,39,40) |
| InChIKey | WTTXBWVGGNDSDQ-UHFFFAOYSA-N |
| XLogP | 4.07 |
| TPSA | 155.06 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 675.78 |
| LogP ≤ 5 | 4.07 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154961241 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.